Zix Corporation Reports Another Record-High Revenue Quarter as Company Announces Second Quarter 2009 Financi...(--------- --------- Net cash...),Health

Date:7/28/2009

--------- --------- Net cash (used in) provided by operating activities (239,000) 1,143,000 Investing activities: Purchases of property and equipment (515,000) (544,000) Restricted cash investments and marketable securities, net 3,000 1,734,000 ----- --------- Net cash (used in) provided by investing activities (512,000) 1,190,000 Financing activities: Proceeds from exercise of stock options - 150,000 ------- ------- Net cash provided by financing activities - 150,000 ------- ------- Increase (decrease) in cash and cash equivalents (751,000) 2,483,000 Cash and cash equivalents, beginning of period 13,245,000 10,524,000 ---------- ---------- Cash and cash equivalents, end of period $12,494,000 $13,007,000 =========== =========== ZIX CORPORATION RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited) Three Months Ended June 30, 2009 -------------------------------- Non-Cash Strategic Stock- Non- Alter- Income based Recurring native Tax Non-GAAP GAAP Comp. Items Review Impact ("Adj.") Results (A) (B) (C
'/>"/>

SOURCE Zix Corporation Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Related medicine news :

1. DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call
2. Danaher Corporation Announces Retirement of Executive Vice President Philip W. Knisely
3. Dialysis Corporation of America Announces Second Quarter 2009 Earnings Release Date
4. Providence Service Corporation to Report Second Quarter 2009 Results on Monday, August 10th After the Market Closes
5. MedCath Corporation to Hold Conference Call on Third Quarter Results
6. Digirad Corporation Reports Second Quarter 2009 Financial Results
7. Service Corporation International Announces Schedule For Its Second Quarter 2009 Earnings Release and Conference Call
8. Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study
9. Align Technology Provides Update on Patent Litigation with Ormco Corporation
10. PTS, Inc. Subsidiary Disability Access Corporation Announces $535,000 in New Contracts and Inspection Orders for July 2009
11. PTS, Inc. Subsidiary Disability Access Corporation Announces $535,000 in New Contracts and Inspection Orders for July 2009